INTELLIGENT BIO SOLUTIONS INC. Cash Flow Statement
INBS|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
INTELLIGENT BIO SOLUTIONS INC. used $10M in operating cash flow and negative free cash flow of $10M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | -$10.2M | -$10.6M | -$8.3M | -$7.0M | -$3.2M |
| Depreciation & Amortization | $974.4K | $814.5K | $814.5K | - | - |
| Operating Cash Flow | -$9.6M | -$7.4M | -$3.4M | -$11.3M | -$498.6K |
| Capital Expenditures | $221.4K | $5.4K | - | - | - |
| Free Cash Flow | -$9.8M | -$7.4M | - | - | - |
| FCF Margin | -314.7% | -587.4% | - | - | - |